Log In
Print
BCIQ
Print
Print this Print this
 

PC-mAb

  Manage Alerts
Collapse Summary General Information
Company Athera Biotechnologies AB
DescriptionHumanized antibody against phosphorylcholine (PC)
Molecular Target Phosphorylcholine (PC)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAtherosclerosis
Indication DetailsTreat patients with an increased risk of atherosclerosis-related cardiovascular events and death
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today